Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues
Translational Vision Science & Technology · 2026
DOI: 10.1167/tvst.15.1.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2026. Verfasst von Saumya Jakati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmic Pathology Laboratory, Kallam Anji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Retinoblastoma, Extracellular Vesicles, Biomarkers, Tumor, Retinal Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the expression of small extracellular vesicle (sEV)-specific markers in retinoblastoma (RB) tumor tissue and to identify the RB-specific extracellular cargo as biomarker.
Methods
Twenty-five treatment-naïve, unilateral RB were included in the study from ophthalmic pathology achieves during January 2020 to December 2022. Demographics, histomorphology, and immunohistochemical analysis were performed on all the samples. The expression of the immunomarkers was graded as faint (+), moderate (++), or marked (+++) compared with immunohistochemistry controls.
Results
In the 25 enucleated RB eyes, CD63 (n = 11 [44%]) and TSG101 (n = 23 [92%]) were more prominently expressed sEV markers in the tumor. CD81 was the least expressed. Of the sEV cargo, HIF1a (n = 22, 88%) followed by KAT2B (n = 21 [84%]) showed increased expression in tumor cells with no expression in normal retina. Vascular endothelial growth factor A was seen in 48% of cases and was expressed in normal retina. All the markers showed heterogenous expression in the tumor.
Conclusions
Although sEV markers are expressed in tumor microenvironment, their expression is heterogenous in tumors. Of the EV markers, tetraspanin CD63 was predominantly expressed in tumor tissues as compared with CD9 and CD81. Among the previously identified EV cargo, HIF1a and KAT2B were found to be expressed in RB tumors, indicating their potential as biomarkers. Translational Relevance: KAT2B, previously identified as EV cargo, showed expression in tumor tissue, validating its biomarker potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ophthalmic Pathology Laboratory, Kallam Anji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India.
- Prof. Krothapalli Ravindranath Ophthalmic Research Biorepository, Kallam Anji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India.
- The Operation Eyesight Universal Institute for Eye Cancer, Kallam Anji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India.
- Prof. Brien Holden Eye Research Centre, Kallam Anji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India.
- School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad, Telangana, India.
Zitieren
APA
Jakati, S., Mocherla, T. R., Pallavi, R., Manukonda, R., Mishra, D. K., Vemuganti, G. K., & Kaliki, S. (2026). Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.15.1.30
Vancouver
Jakati S, Mocherla TR, Pallavi R, Manukonda R, Mishra DK, Vemuganti GK, et al. Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues. Translational Vision Science & Technology. 2026. doi:10.1167/tvst.15.1.30
BibTeX
@article{Jakati2026,
author = {Jakati, Saumya and Mocherla, Tirupathi Rao and Pallavi, Rani and Manukonda, Radhika and Mishra, Dilip Kumar and Vemuganti, Geeta Kashyap and Kaliki, Swathi},
title = {Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues},
journal = {Translational Vision Science & Technology},
year = {2026},
doi = {10.1167/tvst.15.1.30}
}
EUVIMED